COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED

Detalhes bibliográficos
Autor(a) principal: Leite Guedes, Idrys Henrique
Data de Publicação: 2021
Outros Autores: Dantas dos Santos , Gregório, Freire Viana, Antônio Bonildo, da Silva Araújo, Geldane, Câmara Pinto dos Santos, Tálio, Gonçalves Moreno, Cláudia Jassica, Tavares Donato, Silvia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Health and Society
Texto Completo: https://www.periodicojs.com.br/index.php/hs/article/view/454
Resumo: Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.
id IEPP-2_fcff1309ab9b6bb8ffd8949b76554d97
oai_identifier_str oai:ojs.pkp.sfu.ca:article/454
network_acronym_str IEPP-2
network_name_str Health and Society
repository_id_str
spelling COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USEDCOVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USEDCOVID-19; Therapeutic Approaches; Drug TherapyCOVID-19Therapeutic ApproachesDrug TherapySince December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.Editora Acadêmica Periodicojs2021-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.periodicojs.com.br/index.php/hs/article/view/45410.51249/hes01.04.2021.454Health and Society; Vol. 1 No. 04 (2021)Health and Society; v. 1 n. 04 (2021)2763-572410.51249/hs.v1i04reponame:Health and Societyinstname:Instituto de Ensino e Pesquisa Periodicojsinstacron:IEPPporhttps://www.periodicojs.com.br/index.php/hs/article/view/454/323Copyright (c) 2021 Health and Societyinfo:eu-repo/semantics/openAccessLeite Guedes, Idrys HenriqueDantas dos Santos , GregórioFreire Viana, Antônio Bonildoda Silva Araújo, GeldaneCâmara Pinto dos Santos, TálioGonçalves Moreno, Cláudia JassicaTavares Donato, Silvia2022-01-11T13:27:40Zoai:ojs.pkp.sfu.ca:article/454Revistahttps://www.periodicojs.com.br/index.php/hs/PRIhttps://www.periodicojs.com.br/index.php/hs/oaijournalofhealthandsociety@gmail.com || periodicojs@gmail.com2763-57242763-5724opendoar:2022-01-11T13:27:40Health and Society - Instituto de Ensino e Pesquisa Periodicojsfalse
dc.title.none.fl_str_mv COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
title COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
spellingShingle COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
Leite Guedes, Idrys Henrique
COVID-19; Therapeutic Approaches; Drug Therapy
COVID-19
Therapeutic Approaches
Drug Therapy
title_short COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
title_full COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
title_fullStr COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
title_full_unstemmed COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
title_sort COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
author Leite Guedes, Idrys Henrique
author_facet Leite Guedes, Idrys Henrique
Dantas dos Santos , Gregório
Freire Viana, Antônio Bonildo
da Silva Araújo, Geldane
Câmara Pinto dos Santos, Tálio
Gonçalves Moreno, Cláudia Jassica
Tavares Donato, Silvia
author_role author
author2 Dantas dos Santos , Gregório
Freire Viana, Antônio Bonildo
da Silva Araújo, Geldane
Câmara Pinto dos Santos, Tálio
Gonçalves Moreno, Cláudia Jassica
Tavares Donato, Silvia
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Leite Guedes, Idrys Henrique
Dantas dos Santos , Gregório
Freire Viana, Antônio Bonildo
da Silva Araújo, Geldane
Câmara Pinto dos Santos, Tálio
Gonçalves Moreno, Cláudia Jassica
Tavares Donato, Silvia
dc.subject.por.fl_str_mv COVID-19; Therapeutic Approaches; Drug Therapy
COVID-19
Therapeutic Approaches
Drug Therapy
topic COVID-19; Therapeutic Approaches; Drug Therapy
COVID-19
Therapeutic Approaches
Drug Therapy
description Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.periodicojs.com.br/index.php/hs/article/view/454
10.51249/hes01.04.2021.454
url https://www.periodicojs.com.br/index.php/hs/article/view/454
identifier_str_mv 10.51249/hes01.04.2021.454
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.periodicojs.com.br/index.php/hs/article/view/454/323
dc.rights.driver.fl_str_mv Copyright (c) 2021 Health and Society
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Health and Society
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Editora Acadêmica Periodicojs
publisher.none.fl_str_mv Editora Acadêmica Periodicojs
dc.source.none.fl_str_mv Health and Society; Vol. 1 No. 04 (2021)
Health and Society; v. 1 n. 04 (2021)
2763-5724
10.51249/hs.v1i04
reponame:Health and Society
instname:Instituto de Ensino e Pesquisa Periodicojs
instacron:IEPP
instname_str Instituto de Ensino e Pesquisa Periodicojs
instacron_str IEPP
institution IEPP
reponame_str Health and Society
collection Health and Society
repository.name.fl_str_mv Health and Society - Instituto de Ensino e Pesquisa Periodicojs
repository.mail.fl_str_mv journalofhealthandsociety@gmail.com || periodicojs@gmail.com
_version_ 1797047896064917504